Barclays maintains Kanzhun at Overweight, lowers price target to $17 from $20
Barclays kept Kanzhun's rating at Overweight but reduced its price target to $17 from $20, a 15% cut. The new target suggests a 36.1% upside from the Nov 12 close of $12.49.



